BNP PARIBAS FINANCIAL MARKETS - NOVAVAX INC ownership

NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 215 filers reported holding NOVAVAX INC in Q2 2023. The put-call ratio across all filers is 1.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of NOVAVAX INC
ValueSharesWeighting
Q3 2023$5,669,630
+79.5%
585,098
+37.6%
0.01%
+75.0%
Q2 2023$3,158,939
-33.5%
425,160
-38.0%
0.00%
-42.9%
Q1 2023$4,752,040
-25.0%
685,720
+13.9%
0.01%
-30.0%
Q4 2022$6,339,296
-99.9%
602,011
+65.0%
0.01%
-16.7%
Q3 2022$7,176,387,000
-2.1%
364,805
+222.8%
0.01%
+9.1%
Q2 2022$7,329,032,000
-42.5%
113,003
-13.8%
0.01%
-35.3%
Q1 2022$12,750,435,000
-30.0%
131,047
+52.1%
0.02%
-32.0%
Q4 2021$18,215,815,000
+108.7%
86,137
+259.2%
0.02%
+108.3%
Q3 2021$8,726,922,000
+118.0%
23,979
+27.2%
0.01%
+140.0%
Q2 2021$4,002,468,000
-29.5%
18,852
-39.8%
0.01%
-37.5%
Q1 2021$5,676,453,000
-16.4%
31,308
-48.6%
0.01%
-38.5%
Q4 2020$6,790,178,000
+296.7%
60,893
+285.5%
0.01%
+550.0%
Q3 2020$1,711,497,000
+268.1%
15,796
+183.1%
0.00%
+100.0%
Q2 2020$465,010,000
+248.0%
5,579
-43.3%
0.00%
Q1 2020$133,627,000
+499.9%
9,840
+75.8%
0.00%
Q4 2019$22,276,000
+35.6%
5,597
+71.1%
0.00%
Q3 2019$16,425,000
+32.8%
3,272
+55.0%
0.00%
Q2 2019$12,370,0002,1110.00%
Other shareholders
NOVAVAX INC shareholders Q2 2023
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 132,500$2,414,0000.77%
HAP Trading, LLC 130,000$10,673,0000.71%
Mendel Capital Management LLC 23,835$434,0000.51%
Faithward Advisors, LLC 115,912$2,109,0000.50%
Rock Springs Capital Management LP 599,300$10,907,0000.28%
SECTOR GAMMA AS 56,735$1,033,0000.27%
Quantitative Investment Management, LLC 83,072$1,511,0000.25%
LMR Partners LLP 396,100$7,209,0000.13%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 1,333,706$24,273,0000.13%
TSP Capital Management Group, LLC 16,025$292,0000.12%
View complete list of NOVAVAX INC shareholders